GB9715298D0 - Novel method of treatment - Google Patents

Novel method of treatment

Info

Publication number
GB9715298D0
GB9715298D0 GB9715298A GB9715298A GB9715298D0 GB 9715298 D0 GB9715298 D0 GB 9715298D0 GB 9715298 A GB9715298 A GB 9715298A GB 9715298 A GB9715298 A GB 9715298A GB 9715298 D0 GB9715298 D0 GB 9715298D0
Authority
GB
United Kingdom
Prior art keywords
treatment
novel method
novel
method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9715298A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB9715298A priority Critical patent/GB9715298D0/en
Publication of GB9715298D0 publication Critical patent/GB9715298D0/en
Priority claimed from US09/989,572 external-priority patent/US20020052324A1/en
Application status is Pending legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
GB9715298A 1997-07-18 1997-07-18 Novel method of treatment Pending GB9715298D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Applications Claiming Priority (30)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
DZ980173A DZ2563A1 (en) 1997-07-18 1998-07-15 Composition containing an insulin sensitiser an insulin secretagogue and a biguanide anti-hyperglycérnique inhibitor of alpha-glucosidase.
JP2000502777A JP2001510160A (en) 1997-07-18 1998-07-16 Thiazolidinedione, treatment of insulin secretagogue and diabetes using alpha-glucosidase inhibitor
PL98338140A PL338140A1 (en) 1997-07-18 1998-07-16 Method of treating diebetes by means of derivatives of thiazolydinone, of insulin secretion stimulating agent and of alpha-glucosidase inhibitor
BR9810292-3A BR9810292A (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucosidase inhibitor
CN98807147A CN1263467A (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
AP200001735A AP200001735A0 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor
HU0003626A HU0003626A3 (en) 1997-07-18 1998-07-16 Pharmaceutical composition for treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
CA002297133A CA2297133A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
IL13390798A IL133907D0 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
KR1020007000517A KR20010021952A (en) 1997-07-18 1998-07-16 Treatment of Diabetes with Thiazolidinedione, Insulin Secretagogue and Alpha Glucocidase Inhibitor
EP98935129A EP1001784A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor
AU84490/98A AU8449098A (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
TR2000/00133T TR200000133T2 (en) 1997-07-18 1998-07-16 Thiazolidinedione diabetes with insulin secretagogue and an alpha glucosidase inhibitor (sugar disease) therapy.
PCT/GB1998/002112 WO1999003478A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
IDW20000077A ID23804A (en) 1997-07-18 1998-07-16 Treatment of diabetes with insulin secretagogues thiazolidinediones and alpha-glucosidase inhibitors
MA25172A MA24608A1 (en) 1997-07-18 1998-07-16 Compositions containing an insulin sensitiser, an insulin secretagogue and an anti-inhibitor agent heperglycemique alphat-glugosidase.
ARP980103482A AR016350A1 (en) 1997-07-18 1998-07-16 Use of an insulin sensitiser, an insulin secretagogue and an inhibitor antihyperglycaemic agent for alpha-glucosidase prepararmedicamentos
PE1998000630A PE99499A1 (en) 1997-07-18 1998-07-16 pharmaceutical composition for the treatment of diabetes
SK61-2000A SK612000A3 (en) 1997-07-18 1998-07-16 Application of insulin sensitiser, insulin secretagogue and alpha glucosidase inhibitor antihyperglycaemic agent for the treatment of diabetes mellitus and conditions associated with diabetes mellitus and a pharmaceutical composition
EA200000140A EA200000140A1 (en) 1997-07-18 1998-07-16 Method for treating diabetes thiazolidindione, a means for strengthening insulin secretion, and alpha-glucosidase inhibitor
UY25101A UY25101A1 (en) 1997-07-18 1998-07-17 Method for the treatment of diabetes mellitus and associated conditions
ZA9806364A ZA9806364B (en) 1997-07-18 1998-07-17 Novel method of treatment.
CO98040749A CO4940489A1 (en) 1997-07-18 1998-07-17 New treatment method cinemas associated therewith in mammals
ARP990103110A AR019724A2 (en) 1997-07-18 1999-06-28 pharmaceutical composition useful for the treatment of diabetes mellitus and associated conditions
BG104062A BG104062A (en) 1997-07-18 2000-01-06 Treatment of diabetes with thiazolidindion, stimulant of insulin secretion and alpha-glucosidase inhibitor
NO20000230A NO20000230D0 (en) 1997-07-18 2000-01-17 Treatment of diabetes with thiazolidinedione insulin sekretagogue and <alpha> glucosidase
OA1200000013A OA11312A (en) 1997-07-18 2000-01-18 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor.
US09/989,572 US20020052324A1 (en) 1997-07-18 2001-11-20 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
US10/322,982 US20030092750A1 (en) 1997-07-18 2002-12-18 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor

Publications (1)

Publication Number Publication Date
GB9715298D0 true GB9715298D0 (en) 1997-09-24

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9715298A Pending GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Country Status (27)

Country Link
EP (1) EP1001784A1 (en)
JP (1) JP2001510160A (en)
KR (1) KR20010021952A (en)
CN (1) CN1263467A (en)
AP (1) AP200001735A0 (en)
AR (2) AR016350A1 (en)
AU (1) AU8449098A (en)
BG (1) BG104062A (en)
BR (1) BR9810292A (en)
CA (1) CA2297133A1 (en)
CO (1) CO4940489A1 (en)
DZ (1) DZ2563A1 (en)
EA (1) EA200000140A1 (en)
GB (1) GB9715298D0 (en)
HU (1) HU0003626A3 (en)
ID (1) ID23804A (en)
IL (1) IL133907D0 (en)
MA (1) MA24608A1 (en)
NO (1) NO20000230D0 (en)
OA (1) OA11312A (en)
PE (1) PE99499A1 (en)
PL (1) PL338140A1 (en)
SK (1) SK612000A3 (en)
TR (1) TR200000133T2 (en)
UY (1) UY25101A1 (en)
WO (1) WO1999003478A1 (en)
ZA (1) ZA9806364B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
ES2291210T3 (en) * 1999-06-21 2008-03-01 Eli Lilly And Company thiazolidinediones synergistic with glucagon peptide-1 type and its agonists for treating insulin-dependent diabetes not.
CA2673615C (en) * 2000-01-21 2013-07-16 Novartis Ag Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
JP4917712B2 (en) * 2000-02-24 2012-04-18 武田薬品工業株式会社 Pharmaceutical combination
EP1295609A4 (en) * 2000-02-24 2004-11-03 Takeda Chemical Industries Ltd Drugs containing combined active ingredients
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
FR2832930A1 (en) * 2001-12-03 2003-06-06 Lipha Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a thiazolidinedione derivative and use thereof for the preparation of medicaments for the treatment of diabetes
KR20100012105A (en) 2003-10-31 2010-02-05 다케다 야쿠힌 고교 가부시키가이샤 Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
CN101103993B (en) 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 Hypoglycemic medicine composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2101866T3 (en) * 1991-08-26 1997-07-16 Upjohn Co liquid food product containing 3-guanidinopropionic.
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
AR019724A2 (en) 2002-03-13
PL338140A1 (en) 2000-09-25
MA24608A1 (en) 1999-04-01
CO4940489A1 (en) 2000-07-24
ID23804A (en) 2000-05-11
HU0003626A2 (en) 2001-05-28
EA200000140A1 (en) 2000-06-26
EP1001784A1 (en) 2000-05-24
JP2001510160A (en) 2001-07-31
OA11312A (en) 2003-10-24
TR200000133T2 (en) 2000-09-21
NO20000230D0 (en) 2000-01-17
HU0003626A3 (en) 2001-12-28
AU8449098A (en) 1999-02-10
PE99499A1 (en) 1999-12-18
NO20000230L (en) 2000-01-17
DZ2563A1 (en) 2003-02-15
AR016350A1 (en) 2001-07-04
BG104062A (en) 2000-11-30
BR9810292A (en) 2000-09-19
WO1999003478A1 (en) 1999-01-28
CA2297133A1 (en) 1999-01-28
ZA9806364B (en) 2000-01-17
IL133907D0 (en) 2001-04-30
AP200001735A0 (en) 2000-03-31
CN1263467A (en) 2000-08-16
UY25101A1 (en) 2000-12-29
SK612000A3 (en) 2000-07-11
KR20010021952A (en) 2001-03-15

Similar Documents

Publication Publication Date Title
GB2337763B (en) Methods of treating preform elements
AP1428A (en) Disinfectant and method of making
GB2298440B (en) Well treatment
EG21382A (en) Treatment of water
AU9035498A (en) Method for treating pain
GB9617990D0 (en) Treatment of pain
PL332206A1 (en) Method of obtaining ecteinascidine compounds
ZA9605088B (en) Methods of preventing or treating allergles
PL184242B1 (en) Method of manipulating
AU6056798A (en) Method of sterilization
GB9401520D0 (en) Treatment of poultry
AU9028798A (en) Method of improving drug treatment
EP0923293A4 (en) Treatment of diarrhea
AU6578998A (en) Method of treatment of migraine
EP1027450A4 (en) Method of dna shuffling
EP0771203A4 (en) Method of treating sweat-related conditions
PL334375A1 (en) Method of obtaining toltherodine
PL329295A1 (en) Method of obtaining oxazolydinones
GB9407135D0 (en) Treatment of osteoporosis
GB9606736D0 (en) Therapeutic method
IL127497D0 (en) Method of treating psychiatric conditions
GB9721506D0 (en) Treatment of diseases
PL324284A1 (en) Methods of treating diabetes
PL336693A1 (en) Novel method of obtaining farmacologically active substances
HRP970505A2 (en) Method of medical treatment